Hypera to acquire portfolio of brands from Sanofi

14 July 2021 - Deborah Wilkes

Brazil’s Hypera Pharma is acquiring a portfolio of OTC and prescription brands – including the analgesic AAS and the herbal medicine Naturetti – from Sanofi for USD190 million.